CN102068444B - Ointment for treating skin diseases - Google Patents

Ointment for treating skin diseases Download PDF

Info

Publication number
CN102068444B
CN102068444B CN2011100099390A CN201110009939A CN102068444B CN 102068444 B CN102068444 B CN 102068444B CN 2011100099390 A CN2011100099390 A CN 2011100099390A CN 201110009939 A CN201110009939 A CN 201110009939A CN 102068444 B CN102068444 B CN 102068444B
Authority
CN
China
Prior art keywords
grams
ointment
milligrams
milliliters
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011100099390A
Other languages
Chinese (zh)
Other versions
CN102068444A (en
Inventor
朱五元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011100099390A priority Critical patent/CN102068444B/en
Publication of CN102068444A publication Critical patent/CN102068444A/en
Application granted granted Critical
Publication of CN102068444B publication Critical patent/CN102068444B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses an ointment for treating skin diseases. 10 grams of ointment is prepared from 10 milligrams of miconazole nitrate, 1 milligram of triamcinolone acetate, 3,000 units of neomycin sulfate, 100 milligrams of metronidazole and 50 milligrams of borneol in the presence of an ointment auxiliary material, wherein the ointment auxiliary material is single emulsion; the single emulsion is a compound preparation and comprises the following components by weight (volume): 35 grams of glycerol monostearate, 130 to 150 grams of stearic acid, 70 grams of albolene, 20 milligrams of azone, 1 grams of ethylparaben, 560 to 580 milliliters of water, 4 grams of borax, 4 grams of lauryl sodium sulfate, 10 to 20 milliliters of triethanolamine, 160 milliliters of glycerol and 3 grams of allantoin. According to the formula, the ointment is used for tens of thousands of patients clinically, the satisfaction of the patients is 100 percent, the ointment does not have special taboos, and an anaphylactic reaction and discomfort do not occur.

Description

The dermopathic ointment of a kind of treatment
Technical field
The present invention relates to the dermopathic ointment of a kind of treatment.
Background technology
Ointment has consequence in treating for skin disease, the body innerlich anwenden is difficult to reach skin surface, and cuticular layer, the squama position.Have only the external emulsifiable paste to add antibiotic, antipruritic, infiltration, chemosmotic medicine, just can play the combination of inner and outside and treat dermopathic purpose.
Summary of the invention
Technical problem to be solved by this invention provides the dermopathic ointment of a kind of treatment.
The present invention adopts technical scheme:
The dermopathic ointment of a kind of treatment is an example to prepare 10 gram ointment: 10 milligrams of miconazole nitrates, and 1 milligram of triamcinolone acetonide acetate, polygynax 3000 units, 100 milligrams of metronidazoles, 50 milligrams of Borneolum Syntheticums are equipped with the ointment adjuvant.
Said ointment adjuvant is single breast, and said single breast is a compound preparation, and the prescription of single breast is: glyceryl monostearate 35 grams, stearic acid 130-150 gram; White vaseline 70 grams, 20 milligrams of azones, ethyl hydroxybenzoate 1 gram; Water 560-580 milliliter, Borax 4 grams, sodium lauryl sulphate 4 grams; Triethanolamine 10-20 milliliter, 160 milliliters of glycerol, allantoin 3 grams.
In inventor's treating skin disease of four more than ten years, summed up the effective medicine for external use of a cover, cured ten hundreds of dermatosis patients.And antifungal drug for oral administration is to liver, kidney, and infringement is big, and is little to the skin surface effect, selects for use medicine for external use safety to have no side effect.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is elaborated.
The dermopathic ointment of a kind of treatment is an example to prepare 10 gram ointment: 10 milligrams of miconazole nitrates, and 1 milligram of triamcinolone acetonide acetate, polygynax 3000 units, 100 milligrams of metronidazoles, 50 milligrams of Borneolum Syntheticums are equipped with the ointment adjuvant.Get final product by this proportional arrangement during large-scale production.
Said ointment adjuvant is single breast, and said single breast is a compound preparation, and the prescription of single breast is: glyceryl monostearate 35 grams, stearic acid 130-150 gram; White vaseline 70 grams, 20 milligrams of azones, ethyl hydroxybenzoate 1 gram; Water 560-580 milliliter, Borax 4 grams, sodium lauryl sulphate 4 grams; Triethanolamine 10-20 milliliter, 160 milliliters of glycerol, allantoin 3 grams.In order to regulate the hardness of ointment, the stearic acid in single Ruzhong, triethanolamine, water, glycerol can suitably increase and decrease as required.
Packing: medicinal round plastic box 10-20 gram.
Pharmaceutical analysis, pharmacological action:
Miconazole nitrate is the broad-spectrum antifungal medicine, and polygynax is effective to multiple Grain-positive and negative bacteria, and metronidazole is effective to various acarids, and triamcinolone acetonide acetate has the effect of antiinflammatory antiallergic and antipruritic, and Borneolum Syntheticum has anticorrosion antipruritic, clearing away heat to alleviate pain, immersional wetting.
Character: be the milky ointment of emulsion-type substrate.
Indication: eczema, dermatitis, tinea corporis, tinea cruris, tinea capitis, acne rosacea, scabies.
Usage and dosage: external, directly wipe in the affected part of cleaning, two to three times on the one
Storage: sealing, preserve (being no more than 20 ℃) in the cool
Two more than ten years of 21 years old trouble skin infection of the big great waves of Mei Yuan town, case 1. Fuping County scape man, various big hospital is failed to respond to any medical treatment, and fully recovers a course of treatment with the treatment of skin bacterium frost emulsifiable paste.(30 days course of treatment)
Five-pointed star village, Po Tou town, case 2. Pucheng County ten thousand religion men suffered from neurodermatitis in 36 years old, with recovery from illness course of treatment of skin bacterium frost emulsifiable paste treatment.
The peaceful town king of case 3. Pucheng County parties is just printing the man and was suffering from tinea cruris, neurodermatitis in 61 years old, with two recoveries from illness course of treatment of skin bacterium frost emulsifiable paste treatment.
Case 4. Weinan City Zhou Zuocheng man suffered from neurodermatitis, acne rosacea for many years in 60 years old, with three recoveries from illness course of treatment of skin bacterium frost emulsifiable paste treatment.
31 years old trouble skin infection of case 5. Baishui County Lei Cun township passage village Li Yuan man fully recovered with the treatment of skin bacterium frost emulsifiable paste for many years a course of treatment.
Above prescription is through the thousands of examples of clinical use, and effect satisfied 100% is effective, does not have special taboo, does not also find anaphylaxis, the thing of discomfort.
Should be understood that, concerning those of ordinary skills, can improve or conversion, and all these improvement and conversion all should belong to the protection domain of accompanying claims of the present invention according to above-mentioned explanation.

Claims (2)

1. the dermopathic ointment of treatment is characterized in that, is example to prepare 10 gram ointment: 10 milligrams of miconazole nitrates, and 1 milligram of triamcinolone acetonide acetate, polygynax 3000 units, 100 milligrams of metronidazoles, 50 milligrams of Borneolum Syntheticums are equipped with the ointment adjuvant.
2. ointment according to claim 1 is characterized in that, said ointment adjuvant is single breast, and said single breast is a compound preparation; The prescription of single breast is: glyceryl monostearate 35 grams, stearic acid 130-150 gram, white vaseline 70 grams, 20 milligrams of azones; Ethyl hydroxybenzoate 1 gram, water 560-580 milliliter, Borax 4 grams, sodium lauryl sulphate 4 grams; Triethanolamine 10-20 milliliter, 160 milliliters of glycerol, allantoin 3 grams.
CN2011100099390A 2011-01-18 2011-01-18 Ointment for treating skin diseases Expired - Fee Related CN102068444B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100099390A CN102068444B (en) 2011-01-18 2011-01-18 Ointment for treating skin diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100099390A CN102068444B (en) 2011-01-18 2011-01-18 Ointment for treating skin diseases

Publications (2)

Publication Number Publication Date
CN102068444A CN102068444A (en) 2011-05-25
CN102068444B true CN102068444B (en) 2012-08-15

Family

ID=44027324

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100099390A Expired - Fee Related CN102068444B (en) 2011-01-18 2011-01-18 Ointment for treating skin diseases

Country Status (1)

Country Link
CN (1) CN102068444B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102920997B (en) * 2012-11-16 2013-08-14 徐汝津 Compound tinea ointment
CN103933051B (en) * 2014-05-12 2014-12-24 广东台城制药股份有限公司 Triamcinolone acetonide acetat and preparation method thereof
CN105106487A (en) * 2015-09-24 2015-12-02 青岛海之源智能技术有限公司 Metronidazole and miconazole nitrate compound ointment and method for preparing same
CN105497043B (en) * 2015-12-18 2019-01-18 汶上县皮肤病防治站 A kind of externally applied drug and preparation method thereof for treating skin eczema and eczema-like dermatitis
CN106074572A (en) * 2016-08-09 2016-11-09 梁东荣 One treats dermopathic medicine and its preparation method and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1324607A (en) * 2000-03-27 2001-12-05 塔罗制药工业有限公司 Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt
CN1706365A (en) * 2005-05-09 2005-12-14 凌沛学 Reversibly hot gelified water soluble medicine composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1324607A (en) * 2000-03-27 2001-12-05 塔罗制药工业有限公司 Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt
CN1706365A (en) * 2005-05-09 2005-12-14 凌沛学 Reversibly hot gelified water soluble medicine composition

Also Published As

Publication number Publication date
CN102068444A (en) 2011-05-25

Similar Documents

Publication Publication Date Title
CN102068444B (en) Ointment for treating skin diseases
Phillips Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories
CN102397178A (en) Plant drug mosquito repelling liquid
CN108853003A (en) A kind of Nifuratel-Nysfungin soft-capsule type suppository and preparation method thereof
CN109985069B (en) Probiotic compositions and uses thereof
CN101601750A (en) A kind of specific beriberi medicament
CN101829130A (en) Compound resveratrol anti-inflammatory and itching relieving medicament combination and purpose thereof
CN102000093A (en) External ointment for treating impetigo
CN101371899B (en) Medicine for treating tympanitis
Lee et al. A case of anaphylactic shock attributed to latex allergy during gastric cancer surgery
CN101134094A (en) Liniment for treating skin pruritus, eczema and scaly tetter
CN101433518A (en) Compound ofloxacin injection for animals
CN101380328B (en) Medicine for treating coryza and its preparation method
CN1244332C (en) Sarcandra extract and its application
CN103462951B (en) Application of scopariusins in preparation of medicine treating or preventing canker sore
CN105477010A (en) Antibacterial nursing spray
CN100352449C (en) Medicament composition for treating tinea pedis and tinea corporis
CN103585147B (en) Application of Nitrosporeusines A in preparation of oral ulcer treatment or prevention medicines
CN1103222C (en) External use medicinal liquid for treating psoriasis
CN101978968B (en) Medicament for treating tympanitis
CN101843626A (en) Tincture for treating acne
CN102920997B (en) Compound tinea ointment
CN101254305B (en) Composite nasal cavity preparations for curing allergic rhinitis
CN100352467C (en) Chinese medicinal composition for treating upper respiratory tract infection
CN1301727C (en) Externally applied Chinese medicine preparation for treating skin disease and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120815

Termination date: 20130118